Total Assets - Calithera Biosciences Inc (F:2CB) - Alpha Spread
C

Calithera Biosciences Inc
F:2CB

Watchlist Manager
Calithera Biosciences Inc
F:2CB
Watchlist
Price: 3.86 EUR -2.53% Market Closed
Market Cap: 1m EUR
Have any thoughts about
Calithera Biosciences Inc?
Write Note

Calithera Biosciences Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Calithera Biosciences Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
C
Calithera Biosciences Inc
F:2CB
Total Assets
$28.7m
CAGR 3-Years
-45%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Assets
$141.9B
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$53.6B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Total Assets
$90.9B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$20.1B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$36.1B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Calithera Biosciences Inc's Total Assets?
Total Assets
28.7m USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Total Assets amounts to 28.7m USD.

What is Calithera Biosciences Inc's Total Assets growth rate?
Total Assets CAGR 5Y
-32%

Over the last year, the Total Assets growth was -56%. The average annual Total Assets growth rates for Calithera Biosciences Inc have been -45% over the past three years , -32% over the past five years .

Back to Top